Cirugia Cardiovascular最新文献

英文中文

C20. INFECCIÓN POR MYCOBACTERIUM CHIMAERA: EXPERIENCIA EN UN HOSPITAL TERCIARIO ap 3605。化学分枝杆菌感染：在第三方医院的经验

IF 0.3 Q4 SURGERY

Cirugia Cardiovascular

Pub Date : 2025-05-01 DOI: 10.1016/j.circv.2025.01.011

A. Alonso Álvarez, L. Ramos Merino, S. Cebezal Iglesias, R. Fernández Varela, B. Fernández Pérez, J. Cuenca Castillo, D. Brandariz Núñez, E. Sánchez Vidal, D. Sousa Regueiro, E. Míguez Rey

引用次数: 0

C10. ESTRATEGIA DE ABORDAJE HÍBRIDA EN ENDOCARDITIS VALVULAR TRICÚSPIDE POR ELECTRODO DE MARCAPASOS C10。电子标记三元Valuar内核混合基础战略

IF 0.3 Q4 SURGERY

Cirugia Cardiovascular

Pub Date : 2025-05-01 DOI: 10.1016/j.circv.2025.01.019

O. Leal Fernández, Á. Granda Bauza, D. Sánchez Valenzuela, J. Ramírez Batista, M.P. Benito Martinez, J. Abril Victorino, E. Corral Armas, L.J. Alonso Pérez

引用次数: 0

C19. ENDOCARDITIS INFECCIOSA EN PACIENTES CON CARDIOPATÍAS CONGÉNITAS EN UN HOSPITAL DE TERCER NIVEL C19。三级医院中先天性心脏病患者的感染性内分泌疾病

IF 0.3 Q4 SURGERY

Cirugia Cardiovascular

Pub Date : 2025-05-01 DOI: 10.1016/j.circv.2025.01.025

M.P. Egea Arias, L. Ramos Merino, R. Fernández Varela, A. Alonso Álvarez, B. Pernas Souto, M.D. Sousa Regueiro, L. Gutiérrez Fernández, E. Miguez Rey, E. Sánchez Vidal

引用次数: 0

Efficacy of respiratory physiotherapy preceding to heart surgery with extracorporeal circulation 体外循环心脏手术前呼吸理疗的功效

IF 0.3 Q4 SURGERY

Cirugia Cardiovascular

Pub Date : 2025-05-01 DOI: 10.1016/j.circv.2024.03.012

Eloy Rueda-Gomariz , Carlos A. Castillo-Sarmiento , José Ramón Muñoz-Rodríguez , Inmaculada Ballesteros-Yánez

Introduction and objectives

Heart surgery is one of the most important tools for the treatment of cardiovascular diseases. Postoperative pulmonary complications in patients undergoing heart surgery represent a meaningful clinical problem.

Respiratory physiotherapy is essential in the management of patients during postoperative period, contributing to a better prognosis.

Our objective is to evaluate the efficacy of respiratory physiotherapy prior to cardiac surgery in reducing postoperative complications and hospital stay.

Methods

Randomized, controlled and observational study. A group of 92 patients who underwent heart surgery with extracorporeal circulation were analyzed in the Hospital Puerta del Mar (Spain), divided into 2 groups (control group and experimental group with previous respiratory physiotherapy). We study different postoperative complications and hospital stay.

Results

Atelectasis, pleural effusion, and sternal dehiscence were altered between both groups. An improvement in the intubation time and the reintubation rate was reported in the experimental group, in addition, lower oxygen consumption, an improvement in the fulfillment of respiratory physiotherapy following surgery and a shorter overall hospital stay and in the post-operative care unit was also observed.

Conclusion

Fulfillment of respiratory physiotherapy preceding to heart surgery decreases pulmonary complications and hospital stay, as well as accelerates the recovery of the breathing capacity.

前言与目的心脏外科手术是治疗心血管疾病最重要的手段之一。心脏手术患者术后肺部并发症是一个有意义的临床问题。呼吸物理治疗是术后患者管理中必不可少的，有助于更好的预后。我们的目的是评估心脏手术前呼吸物理治疗在减少术后并发症和住院时间方面的疗效。方法随机对照观察研究。对西班牙Puerta del Mar医院行体外循环心脏手术的92例患者进行分析，分为2组（对照组和既往进行呼吸物理治疗的实验组）。我们研究了不同的术后并发症和住院时间。结果两组肺张、胸腔积液、胸骨裂均有明显改变。据报道，实验组的插管时间和再插管率有所改善，此外，还观察到更低的耗氧量，手术后呼吸物理治疗的实现情况有所改善，总住院时间和术后护理单元的时间也有所缩短。结论心脏手术前进行呼吸物理治疗可减少肺部并发症，缩短住院时间，加快呼吸能力的恢复。

{"title":"Efficacy of respiratory physiotherapy preceding to heart surgery with extracorporeal circulation","authors":"Eloy Rueda-Gomariz , Carlos A. Castillo-Sarmiento , José Ramón Muñoz-Rodríguez , Inmaculada Ballesteros-Yánez","doi":"10.1016/j.circv.2024.03.012","DOIUrl":"10.1016/j.circv.2024.03.012","url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>Heart surgery is one of the most important tools for the treatment of cardiovascular diseases. Postoperative pulmonary complications in patients undergoing heart surgery represent a meaningful clinical problem.</div><div>Respiratory physiotherapy is essential in the management of patients during postoperative period, contributing to a better prognosis.</div><div>Our objective is to evaluate the efficacy of respiratory physiotherapy prior to cardiac surgery in reducing postoperative complications and hospital stay.</div></div><div><h3>Methods</h3><div>Randomized, controlled and observational study. A group of 92 patients who underwent heart surgery with extracorporeal circulation were analyzed in the Hospital Puerta del Mar (Spain), divided into 2 groups (control group and experimental group with previous respiratory physiotherapy). We study different postoperative complications and hospital stay.</div></div><div><h3>Results</h3><div>Atelectasis, pleural effusion, and sternal dehiscence were altered between both groups. An improvement in the intubation time and the reintubation rate was reported in the experimental group, in addition, lower oxygen consumption, an improvement in the fulfillment of respiratory physiotherapy following surgery and a shorter overall hospital stay and in the post-operative care unit was also observed.</div></div><div><h3>Conclusion</h3><div>Fulfillment of respiratory physiotherapy preceding to heart surgery decreases pulmonary complications and hospital stay, as well as accelerates the recovery of the breathing capacity.</div></div>","PeriodicalId":42671,"journal":{"name":"Cirugia Cardiovascular","volume":"32 3","pages":"Pages 125-131"},"PeriodicalIF":0.3,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141691051","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

C07. INFECCIONES EN PACIENTES PORTADORES DE DISPOSITIVOS HEARTMATE C07。携带心脏瓣膜的病人的感染

IF 0.3 Q4 SURGERY

Cirugia Cardiovascular

Pub Date : 2025-05-01 DOI: 10.1016/j.circv.2025.01.016

I. Fernandez López, Á. Pedraz, D. Monzón, Z. Blázquez, M. Ruiz, G. Cuerpo, H. Rodríguez-Abella, J. Castrodeza, P. Muñoz, M. Valerio

引用次数: 0

Asociación entre conexión anómala parcial de venas pulmonares y atresia de venas pulmonares 部分肺静脉异常连接与肺静脉闭锁的关联

IF 0.3 Q4 SURGERY

Cirugia Cardiovascular

Pub Date : 2025-05-01 DOI: 10.1016/j.circv.2024.07.004

Hugo A. Argueta-Velásquez, Jorge L. Cervantes-Salazar, Diego B. Ortega-Zhindon, Vincenzo Arenas-Fabbri, Yessica C. García Hernández, Antonio Benita-Bordes

引用次数: 0

C13. ENDOCARDITIS O DEPÓSITOS DE PIROFOSFATO CÁLCICO: UN DESAFÍO DIAGNÓSTICO Y TERAPÉUTICO C13。内核或钙焦磷酸盐沉积：一种诊断和治疗挑战

IF 0.3 Q4 SURGERY

Cirugia Cardiovascular

Pub Date : 2025-05-01 DOI: 10.1016/j.circv.2025.01.022

Á. Granda Bauza, O. Leal Fernández, D. Sánchez Valenzuela, C. Palacios, M.P. Benito Martínez, J. Sola Gallegos, V. Calleja Muñoz, J. Velasco Montes

引用次数: 0

Técnicas de imagen no invasiva en el implante de prótesis valvulares aórticas transcatéter 经导管瓣膜假体植入的非侵入性成像技术

IF 0.3 Q4 SURGERY

Cirugia Cardiovascular

Pub Date : 2025-03-01 DOI: 10.1016/j.circv.2024.01.008

Alberto Bouzas-Mosquera , Cayetana Barbeito-Caamaño , María José Martínez-Sapiña , Susana Otero-Muinelo , José Manuel Vázquez-Rodríguez

Transcatheter aortic valve implantation (TAVI) has been a true revolution in the treatment of severe symptomatic aortic stenosis. Various advances have led to an exponential growth in the number of implants and a progressive reduction in their complication rate. One key factor in the success of TAVI has been the role of non-invasive cardiac imaging techniques in pre-procedural planning and candidate selection. These techniques enable the determination of the type and size of the prosthetic valve to be implanted, prediction of risks, assessment of the suitability of vascular access, procedure monitoring, and post-implant follow-up. This review addresses the role of non-invasive imaging techniques before, during, and after transcatheter aortic valve implantation.

经导管主动脉瓣植入术（TAVI）是治疗严重症状性主动脉瓣狭窄的真正革命。各种各样的进步导致了植入物数量的指数增长和并发症发生率的逐步降低。TAVI成功的一个关键因素是无创心脏成像技术在术前计划和候选人选择中的作用。这些技术能够确定要植入的人工瓣膜的类型和大小，预测风险，评估血管通路的适用性，过程监测和植入后随访。本文综述了无创成像技术在经导管主动脉瓣植入术之前、期间和之后的作用。

引用次数: 0

La importancia de la formación y participación de los cirujanos cardíacos españoles en las terapias TAVI 西班牙心脏外科医生接受培训和参与TAVI治疗的重要性

IF 0.3 Q4 SURGERY

Cirugia Cardiovascular

Pub Date : 2025-03-01 DOI: 10.1016/j.circv.2025.02.001

Víctor X. Mosquera

引用次数: 0

Horizontes expandidos en TAVI: explorando las rutas de acceso no transfemoral para cirujanos cardíacos 拓展 TAVI 的视野：为心脏外科医生探索非经股动脉入路途径

IF 0.3 Q4 SURGERY

Cirugia Cardiovascular

Pub Date : 2025-03-01 DOI: 10.1016/j.circv.2024.01.012

Víctor X. Mosquera

Transcatheter aortic valve implantation (TAVI) has become the primary treatment for symptomatic severe aortic stenosis, particularly in patients over 75 years of age and those at high surgical risk. In the last two decades, the number of TAVI procedures has significantly increased, and this trend is expected to continue. Despite the preference for transfemoral access in TAVI, it is unsuitable for up to 20% of patients due to anatomical contraindications such as inadequate vessel size, heavily calcified iliofemoral vasculature, or extreme vessel tortuosity. This has led to the exploration and development of non-TF TAVI approaches, including intrathoracic and extrathoracic approaches.

The emergence of different access routes for TAVI has not been simultaneous, and the choice between intrathoracic and extrathoracic accesses is multifaceted, influenced by the patient's anatomy, comorbidities, and the expertise of the treating center. The transapical approach, classified as intrathoracic, has been the main non transfemoral alternative for nearly a decade. However, the emergence of extrathoracic accesses, such as the transcarotid and transsubclavian approaches, has broadened the horizons of TAVI, potentially offering better outcomes for specific patient populations.

经导管主动脉瓣植入术（Transcatheter aortic valve implantation， TAVI）已成为重度症状性主动脉瓣狭窄的主要治疗方法，尤其是75岁以上及手术风险高的患者。在过去的二十年里，TAVI手术的数量显著增加，预计这一趋势将继续下去。尽管TAVI首选经股入路，但由于解剖禁忌，如血管大小不足、髂股血管严重钙化或血管极度扭曲，高达20%的患者不适合经股入路。这导致了非tf TAVI入路的探索和发展，包括胸内和胸外入路。TAVI不同入路的出现并非同时发生，胸内和胸外入路的选择是多方面的，受患者解剖结构、合并症和治疗中心专业知识的影响。经根尖入路被归类为胸内入路，近十年来一直是主要的非经股入路选择。然而，胸外入路的出现，如经颈动脉入路和经锁骨下入路，拓宽了TAVI的视野，可能为特定患者群体提供更好的结果。

{"title":"Horizontes expandidos en TAVI: explorando las rutas de acceso no transfemoral para cirujanos cardíacos","authors":"Víctor X. Mosquera","doi":"10.1016/j.circv.2024.01.012","DOIUrl":"10.1016/j.circv.2024.01.012","url":null,"abstract":"<div><div>Transcatheter aortic valve implantation (TAVI) has become the primary treatment for symptomatic severe aortic stenosis, particularly in patients over 75 years of age and those at high surgical risk. In the last two decades, the number of TAVI procedures has significantly increased, and this trend is expected to continue. Despite the preference for transfemoral access in TAVI, it is unsuitable for up to 20% of patients due to anatomical contraindications such as inadequate vessel size, heavily calcified iliofemoral vasculature, or extreme vessel tortuosity. This has led to the exploration and development of non-TF TAVI approaches, including intrathoracic and extrathoracic approaches.</div><div>The emergence of different access routes for TAVI has not been simultaneous, and the choice between intrathoracic and extrathoracic accesses is multifaceted, influenced by the patient's anatomy, comorbidities, and the expertise of the treating center. The transapical approach, classified as intrathoracic, has been the main non transfemoral alternative for nearly a decade. However, the emergence of extrathoracic accesses, such as the transcarotid and transsubclavian approaches, has broadened the horizons of TAVI, potentially offering better outcomes for specific patient populations.</div></div>","PeriodicalId":42671,"journal":{"name":"Cirugia Cardiovascular","volume":"32 2","pages":"Pages 80-87"},"PeriodicalIF":0.3,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141400261","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

首页上一页

下一页尾页

类型

全部化学•材料生命科学医学物理工程技术环境•农林材料科学地球科学法学管理学化学环境科学与生态学计算机科学教育学经济学农林科学人文科学生物学数学物理与天体物理心理学综合性期刊其他工业工程理学历史学农学文学信息工程

数据库

全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley

期刊

Cirugia Cardiovascular

全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.

﹀